Invasive Breast Cancer trials recruiting in Massachusetts

All Invasive Breast Cancer trials nationally

Cities in Massachusetts

Recruiting trials in Massachusetts

• CONFIRM: Magnetic Resonance Guided Radiation Therapy
  NCT04368702 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Massachusetts: Boston
• Sacituzumab Govitecan In TNBC
  NCT04230109 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Massachusetts: Boston, Danvers, Newton
• TRUDI: TDXD+Durva in HER2+/Low IBC
  NCT05795101 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Female · Massachusetts: Boston
• Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer
  NCT04553770 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Massachusetts: Boston